March 15, 2018 | Yokneam-based Israeli startup PixCell, which develops, manufactures, and markets portable medical diagnostic products for simple blood sampling and analysis, announced that it was awarded a 2.5 million Euro (approximately $3 million) grant to “accelerate commercialization of its product the HemoScreen.” The funding will serve to further test the product, the company said. The Hemoscreen is a portable blood analyzer that performs common test including a blood count with results within 5 minutes, PixCell says. The product is CE marked and expected to be FDA cleared during 2018.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Israel Foodtech Firms Meet UK Retailers, Investors In London
April 17, 2024
Facebook comments